{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:31:20Z","timestamp":1789605080995,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41581-022-00549-0","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T13:04:13Z","timestamp":1644843853000},"page":"207-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Kidneys control inter-organ homeostasis"],"prefix":"10.1038","volume":"18","author":[{"given":"Victor G.","family":"Puelles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7175-5062","authenticated-orcid":false,"given":"Tobias B.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"549_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink, H. J. L. et al. Dapagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 383, 1436\u20131446 (2020).","journal-title":"N. Engl. J. Med."},{"key":"549_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","volume":"17","author":"RA DeFronzo","year":"2021","unstructured":"DeFronzo, R. A., Reeves, W. B. & Awad, A. S. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat. Rev. Nephrol. 17, 319\u2013334 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"549_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41586-021-04133-7","volume":"600","author":"L Mulderrig","year":"2021","unstructured":"Mulderrig, L. et al. Aldehyde-driven transcriptional stress triggers an anorexic DNA damage response. Nature 600, 158\u2013163 (2021).","journal-title":"Nature"},{"key":"549_CR4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI135821","volume":"131","author":"F Solagna","year":"2021","unstructured":"Solagna, F. et al. Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs. J. Clin. Invest. 131, e135821 (2021).","journal-title":"J. Clin. Invest."},{"key":"549_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41581-019-0182-z","volume":"15","author":"J Sch\u00f6del","year":"2019","unstructured":"Sch\u00f6del, J. & Ratcliffe, P. J. Mechanisms of hypoxia signalling: new implications for nephrology. Nat. Rev. Nephrol. 15, 641\u2013659 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"549_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","volume":"29","author":"S Patel","year":"2019","unstructured":"Patel, S. et al. GDF15 provides an endocrine signal of nutritional stress in mice and humans. Cell Metab. 29, 707\u2013718.e8 (2019).","journal-title":"Cell Metab."},{"key":"549_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41581-021-00394-7","volume":"17","author":"H Scholz","year":"2021","unstructured":"Scholz, H. et al. Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection. Nat. Rev. Nephrol. 17, 335\u2013349 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"549_CR8","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1681\/ASN.2020101455","volume":"32","author":"S Sears","year":"2021","unstructured":"Sears, S. & Siskind, L. Potential therapeutic targets for cisplatin-induced kidney injury: lessons from other models of AKI and fibrosis. J. Am. Soc. Nephrol. 32, 1559\u20131567 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"549_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0140-6736(20)31759-1","volume":"396","author":"F Braun","year":"2020","unstructured":"Braun, F. et al. SARS-CoV-2 renal tropism associates with acute kidney injury. Lancet 396, 597\u2013598 (2020).","journal-title":"Lancet"},{"key":"549_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021661","volume":"10","author":"T Sen","year":"2021","unstructured":"Sen, T. et al. Association between circulating GDF-15 and cardio-renal outcomes and effect of canagliflozin: results from the CANVAS trial. J. Am. Heart Assoc. 10, e021661 (2021).","journal-title":"J. Am. Heart Assoc."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00549-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00549-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00549-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:47:09Z","timestamp":1733957229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00549-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1038\/s41581-022-00549-0","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"14 February 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}